Cardiovascular risk assessment tools in Asia.


Journal

Journal of clinical hypertension (Greenwich, Conn.)
ISSN: 1751-7176
Titre abrégé: J Clin Hypertens (Greenwich)
Pays: United States
ID NLM: 100888554

Informations de publication

Date de publication:
04 2022
Historique:
revised: 18 07 2021
received: 22 10 2020
accepted: 19 07 2021
pubmed: 5 1 2022
medline: 12 4 2022
entrez: 4 1 2022
Statut: ppublish

Résumé

Cardiovascular disease (CVD) is becoming the most important burden to health care systems in most part of the world, especially in Asia. Aiming at identifying high risk individuals and tailoring preventive treatment, many cardiovascular risk assessment tools have been established and most of them were developed in Western countries. However, these cardiovascular risk assessment tools cannot be used interchangeably without recalibration because of the different risk factor profiles (ie, greater absolute burden of hypertension and lower level of total-cholesterol in Asians and higher prevalence of metabolic disorders in South Asians) and different CVD profiles (higher ratio of stroke/coronary heart disease in Asians) between Western and Asian populations. Original risk models such as Prediction for ASCVD Risk in China (China-PAR) and Japan Arteriosclerosis Longitudinal Study (JALS) score have been developed and well validated for specific countries, while most of countries/regions in Asia are using established models. Due to higher incidence of stroke in Asians, risk factors like hypertension should weigh more in cardiovascular risk assessment comparing with Western populations, but their actual proportions should be based on CVD profiles in specific countries/regions. The authors encourage the development of new cardiovascular risk assessment tools for Asians, if possible. Still, modifying established models with native epidemiological data of risk factor as well as CVD is acceptable in regions where health care resources are insufficient.

Identifiants

pubmed: 34981620
doi: 10.1111/jch.14336
pmc: PMC8989745
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

369-377

Subventions

Organisme : Capital Medical Development Research Fund, Beijing, China

Informations de copyright

© 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC.

Références

Circulation. 2008 Feb 12;117(6):743-53
pubmed: 18212285
BMC Public Health. 2013 Jun 05;13:539
pubmed: 23734670
BMJ. 2007 Jul 21;335(7611):136
pubmed: 17615182
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73
pubmed: 24222018
Indian Heart J. 2016 May-Jun;68(3):391-8
pubmed: 27316504
N Engl J Med. 2020 Feb 20;382(8):717-726
pubmed: 32074419
Circulation. 2016 Nov 8;134(19):1430-1440
pubmed: 27682885
Eur Heart J. 2003 Jun;24(11):987-1003
pubmed: 12788299
Circulation. 2009 May 5;119(17):2408-16
pubmed: 19364974
Hypertension. 2018 Jun;71(6):e13-e115
pubmed: 29133356
Circulation. 2017 Mar 28;135(13):e793-e813
pubmed: 27815375
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
BMJ Open. 2018 Mar 6;8(3):e019335
pubmed: 29511013
J Geriatr Cardiol. 2019 Mar;16(3):182-241
pubmed: 31080465
Indian Heart J. 2017 Jul - Aug;69(4):458-463
pubmed: 28822511
Hypertens Res. 2019 Sep;42(9):1235-1481
pubmed: 31375757
Circulation. 2016 Aug 9;134(6):441-50
pubmed: 27502908
BMJ. 2008 Jun 28;336(7659):1475-82
pubmed: 18573856
J Epidemiol Community Health. 2007 Feb;61(2):115-21
pubmed: 17234869
Circulation. 1998 May 12;97(18):1837-47
pubmed: 9603539
Curr Opin Cardiol. 2017 Jul;32(4):430-436
pubmed: 28505046
Heart Asia. 2010 Jul 06;2(1):15-8
pubmed: 27325935
BMJ. 2017 May 23;357:j2099
pubmed: 28536104
J Hypertens. 2007 Aug;25(8):1578-82
pubmed: 17620952
J Hypertens. 2007 Jan;25(1):73-9
pubmed: 17143176
Circulation. 2008 Dec 16;118(25):2702-9
pubmed: 19106393
Circ J. 2013;77(7):1646-52
pubmed: 23803294
Hypertens Res. 2009 Dec;32(12):1119-22
pubmed: 19763133
J Clin Hypertens (Greenwich). 2022 Apr;24(4):369-377
pubmed: 34981620
Curr Med Res Opin. 2019 Feb;35(2):291-299
pubmed: 29920124
Hypertens Res. 2019 Apr;42(4):567-579
pubmed: 30760890

Auteurs

Yuqing Zhang (Y)

Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Huanhuan Miao (H)

Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Yook-Chin Chia (YC)

Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Selangor Darul Ehsan, Malaysia.
Department of Primary Care Medicine, Faculty of Medicine, University of Malaya Kuala, Lumpur, Malaysia.

Peera Buranakitjaroen (P)

Department of Medicine, Division of Hypertension, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Saulat Siddique (S)

Punjab Medical Center, Lahore, Pakistan.

Jinho Shin (J)

Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, Korea.

Yuda Turana (Y)

School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.

Sungha Park (S)

Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, Korea.

Kelvin Tsoi (K)

JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong.

Chen-Huan Chen (CH)

Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Department of Medicine, Division of Cardiology, Taipei Veterans General Hospital, Taipei, Taiwan.
Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.

Hao-Min Cheng (HM)

Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Department of Medicine, Division of Cardiology, Taipei Veterans General Hospital, Taipei, Taiwan.
Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Department of Medical Education, Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

Yan Li (Y)

Centre for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Huynh Van Minh (HV)

Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue City, Vietnam.

Michiaki Nagai (M)

Department of Internal Medicine, General Medicine and Cardiology, Hiroshima City Asa Hospital, Hiroshima, Japan.

Jennifer Nailes (J)

Department of Preventive and Community Medicine and Research Institute for Health Sciences, University of the East Ramon Magsaysay Memorial Medical Center Inc., Quezon City, Philippines.

Jorge Sison (J)

Department of Medicine, Section of Cardiology, Medical Center Manila, Manila, Philippines.

Arieska Ann Soenarta (AA)

Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia.

Guru Prasad Sogunuru (GP)

MIOT International Hospital, Chennai, Tamil Nadu, India.
College of Medical Sciences, Kathmandu University, Bharatpur, Nepal.

Apichard Sukonthasarn (A)

Department of Internal Medicine, Cardiology Division, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Jam Chin Tay (JC)

Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore.

Boon Wee Teo (BW)

Department of Medicine, Division of Nephrology, Yong Loo Lin School of Medicine, Singapore, Singapore.

Narsingh Verma (N)

Department of Physiology, King George's Medical University, Lucknow, India.

Tzung-Dau Wang (TD)

Department of Internal Medicine, Cardiovascular Center and Division of Cardiology, National Taiwan University Hospital, Taipei City, Taiwan.
Department of Internal Medicine, Division of Hospital Medicine, National Taiwan University Hospital, Taipei City, Taiwan.

Satoshi Hoshide (S)

Department of Medicine, Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.

Kazuomi Kario (K)

Department of Medicine, Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.

Jiguang Wang (J)

Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, the Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH